Cardiac allograft vasculopathy (CAV) causes impaired blood flow in both epicardial vessels and microvasculature and remains a leading cause of posttransplant morbidity and mortality. This study ...
Journal of Nuclear Medicine January 2025, jnumed.124.268275; DOI: https://doi.org/10.2967/jnumed.124.268275 ...
Journal of Nuclear Medicine January 2025, jnumed.124.267769; DOI: https://doi.org/10.2967/jnumed.124.267769 ...
Journal of Nuclear Medicine January 2025, jnumed.124.269268; DOI: https://doi.org/10.2967/jnumed.124.269268 ...
Objectives [11C]JNJ-42491293 is a novel PET tracer for the metabotropic glutamate receptor subtype 2 (mGluR2) targeting an allosteric site as a potential therapeutic mechanism. The mGluR2 is ...
Journal of Nuclear Medicine January 2025, jnumed.124.268578; DOI: https://doi.org/10.2967/jnumed.124.268578 ...
Journal of Nuclear Medicine January 2025, jnumed.124.268998; DOI: https://doi.org/10.2967/jnumed.124.268998 ...
PET Chemistry: The Driving Force in Molecular Imaging describes the development of radiochemicals as concepts move from bench work to clinical products. Molecular targets have been applied as tools ...
Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...
Journal of Nuclear Medicine January 2025, jnumed.124.268233; DOI: https://doi.org/10.2967/jnumed.124.268233 ...
Journal of Nuclear Medicine January 2025, jnumed.124.268365; DOI: https://doi.org/10.2967/jnumed.124.268365 ...